Target intelligence / Profile preview

Gamma-crystallin B (CRYGB)

Target
CRYGB
Molecular classification
Structural protein, Beta/gamma-crystallin family, Crystallin superfamily
01

Overview

Gamma-crystallin B is a highly stable, water-soluble, monomeric protein encoded by the CRYGB gene in humans and is a dominant structural component of the vertebrate eye lens[1][2][5][6]. It belongs to the beta/gamma-crystallin protein superfamily and plays a crucial role in maintaining lens transparency and the lens’s refractive properties[1][2][6]. Unlike other crystallins, gamma-crystallins such as CRYGB typically lack connecting peptides and terminal extensions, and they are differentially regulated after early development[1]. Mutations or age-related changes in gamma-crystallins, including CRYGB, can lead to lens opacification and cataract formation, but CRYGB is not considered a classical therapeutic target such as a receptor, enzyme, or transporter[1][5][6].

Other names
Gamma-crystallin BCRYGBCRYG2Gamma-B-crystallinGamma-crystallin 1-2CTRCT39crystallin gamma Bgamma-crystallin Bcrystallin, gamma 1-2
02

Biological functions

Maintenance of lens transparencyMaintenance of refractive index in the eye lens
03

Disease associations

Cataract (associated with aging and mutations in CRYGB)

Beyond the preview

Go deeper on Gamma-crystallin B (CRYGB).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Gamma-crystallin B (CRYGB).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call